X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA NATCO PHARMA SHASUN PHARMA/
NATCO PHARMA
 
P/E (TTM) x 123.9 33.3 372.2% View Chart
P/BV x 8.5 16.9 50.3% View Chart
Dividend Yield % 0.2 0.7 34.5%  

Financials

 SHASUN PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
NATCO PHARMA
Mar-14
SHASUN PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs94877 10.7%   
Low Rs46424 10.8%   
Sales per share (Unadj.) Rs214.2223.4 95.9%  
Earnings per share (Unadj.) Rs5.331.1 17.2%  
Cash flow per share (Unadj.) Rs15.840.3 39.3%  
Dividends per share (Unadj.) Rs1.005.00 20.0%  
Dividend yield (eoy) %1.40.8 186.1%  
Book value per share (Unadj.) Rs53.3219.5 24.3%  
Shares outstanding (eoy) m56.6233.07 171.2%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x0.32.9 11.2%   
Avg P/E ratio x13.120.9 62.6%  
P/CF ratio (eoy) x4.416.1 27.4%  
Price / Book Value ratio x1.33.0 44.2%  
Dividend payout %18.716.1 116.4%   
Avg Mkt Cap Rs m3,95821,504 18.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1641,128 191.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,1277,389 164.1%  
Other income Rs m229167 137.3%   
Total revenues Rs m12,3567,556 163.5%   
Gross profit Rs m1,0091,793 56.3%  
Depreciation Rs m594304 195.0%   
Interest Rs m415366 113.4%   
Profit before tax Rs m2301,290 17.8%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73309 -23.6%   
Profit after tax Rs m3021,027 29.4%  
Gross profit margin %8.324.3 34.3%  
Effective tax rate %-31.723.9 -132.3%   
Net profit margin %2.513.9 17.9%  
BALANCE SHEET DATA
Current assets Rs m6,8843,681 187.0%   
Current liabilities Rs m8,4563,123 270.8%   
Net working cap to sales %-13.07.6 -171.4%  
Current ratio x0.81.2 69.1%  
Inventory Days Days6289 68.9%  
Debtors Days Days10859 183.3%  
Net fixed assets Rs m4,9707,685 64.7%   
Share capital Rs m113331 34.3%   
"Free" reserves Rs m2,8756,670 43.1%   
Net worth Rs m3,0207,259 41.6%   
Long term debt Rs m1,817955 190.3%   
Total assets Rs m13,34711,957 111.6%  
Interest coverage x1.64.5 34.4%   
Debt to equity ratio x0.60.1 457.4%  
Sales to assets ratio x0.90.6 147.0%   
Return on assets %5.411.7 46.1%  
Return on equity %10.014.2 70.7%  
Return on capital %13.320.7 64.3%  
Exports to sales %46.439.4 117.8%   
Imports to sales %14.25.7 249.9%   
Exports (fob) Rs m5,6222,908 193.3%   
Imports (cif) Rs m1,728421 410.2%   
Fx inflow Rs m5,8433,445 169.6%   
Fx outflow Rs m2,173703 309.2%   
Net fx Rs m3,6692,743 133.8%   
CASH FLOW
From Operations Rs m3981,440 27.6%  
From Investments Rs m-1,635-1,089 150.1%  
From Financial Activity Rs m1,309-353 -371.0%  
Net Cashflow Rs m71-1 -4,778.5%  

Share Holding

Indian Promoters % 39.2 52.0 75.3%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 3.6 7.8 45.9%  
FIIs % 17.6 16.6 105.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 26.0 152.3%  
Shareholders   20,750 25,395 81.7%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   NOVARTIS  ASTRAZENECA PHARMA  DISHMAN PHARMA  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare SHASUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; IT Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the IT sector and power sector witnessing maximum selling pressure.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - PANACEA BIOTECH COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS